Frequently Asked Questions
The market is segmented based on , By Product Type (Point of Care, Clinical Laboratory Analyzer), Application (Cardiovascular and Vascular Surgery, ECMO, Cardiac Catheterization Laboratories, Critical Care Units, Hemodialysis Units), Technology (Optical Detection, Laser Based Detection, Mechanical Detection, Fluorescent Based Detection), End- User (Hospitals, Clinical Laboratories, Ambulatory Surgical Centers, Academic & Research Institutes), Test (Prothrombin Time, Fibrinogen, Activated Partial Thromboplastin Time, Activated Clotting Time, D Dimer, Platelet Function, Heparin and Protamine Dose Response Test for ACT, Others) – Industry Trends and Forecast to 2030.
.
The Global Activated Clotting Time Testing Market size was valued at USD 447.64 USD Million in 2022.
The Global Activated Clotting Time Testing Market is projected to grow at a CAGR of 4.6% during the forecast period of 2023 to 2030.
The major players operating in the market include F. Hoffmann-La Roche Ltd , Siemens , Thermo Fisher Scientific , Abbott , Helena Laboratories Corporation , Sysmex Corporation , NIHON KOHDEN CORPORATION , Instrumentation Laboratory India Pvt ltd , Medtronic , Diagnostica Stago S.A.S , WerfenLifeS.A. , Laboratory Corporation of America Holdings. , Danaher. , Horiba Ltd. , Hycel Medical , Meril Life Sciences Pvt. Ltd. , ACON , BIO GROUP MEDICAL SYSTEM , Beijing Succeeder Technology Inc. , Maccura Biotechnology Co. .
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.
